BSLN.SW
Basilea Pharmaceutica AG
SwissCHFEQUITY
Healthcare
DELAYED
Last price
64.60
▼ 1.00 (1.52%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
65.20
Prev close
65.60
Day high
65.90
Day low
63.50
Volume
73.63K
Market cap
$799.53M
P/E (TTM)
20.57
52W range
44.70 – 65.90
Day trading desk
Gap from prior close
-0.61%
Prior close 65.60
VWAP
64.22
+0.60% from price
Relative volume
3.89×
Unusually busy
Session range
3.78%
63.50 – 65.90
Position in range
46%
Mid range
ATR (14D)
1.71
2.65% of price
Prior day high
65.60
PDH
Prior day low
62.80
PDL
Bid / ask spread
—
Quote not published
Session volume
139.56K
Avg 35.91K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+21.66%
+23.0%
1M
+23.52%
+19.8%
3M
+20.52%
+17.4%
6M
+18.75%
+7.7%
YTD
+18.10%
+5.8%
1Y
+32.11%
+12.1%
3Y
+52.36%
-21.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on BSLN.SW open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
76.90K
Total on file
Fundamentals
Market cap$799.53M
Enterprise value$711.63M
Revenue (TTM)$247.42M
Gross profit$95.27M
EBITDA$60.92M
Net income$52.38M
EPS (TTM)$3.14
Free cash flow$37.58M
Total cash$173.05M
Total debt$83.44M
Book value / share$13.09
Shares outstanding12.38M
Float12.32M
Short % of float—
Dividend yield—
Beta (5Y)0.41
Valuation & profitability ratios
Trailing P/E20.57
Forward P/E15.07
PEG ratio-0.08
Price / sales—
Price / book4.94
EV / revenue2.88
EV / EBITDA11.68
Gross margin38.51%
Operating margin26.90%
Profit margin21.17%
Return on equity39.46%
Return on assets13.69%
Debt / equity51.40
Current ratio6.60
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $232.38M | $208.54M | $157.63M | $147.76M | — | +11.4% |
| Operating revenue | $232.38M | $208.54M | $157.63M | $147.76M | — | +11.4% |
| Cost of revenue | $39.32M | $38.68M | $26.79M | $24.60M | — | +1.7% |
| Gross profit | $193.06M | $169.86M | $130.84M | $123.16M | — | +13.7% |
| Research & development | $105.89M | $77.14M | $77.85M | $73.80M | — | +37.3% |
| Selling, general & admin | $35.62M | $31.54M | $33.78M | $30.82M | — | +12.9% |
| Total operating expense | $141.51M | $108.69M | $111.64M | $104.62M | — | +30.2% |
| Operating income | $51.55M | $61.18M | $19.20M | $18.54M | — | -15.7% |
| Net interest income | -$2.09M | -$2.93M | -$9.51M | -$9.52M | — | +28.7% |
| Pre-tax income | $45.88M | $60.26M | $10.46M | $12.10M | — | -23.9% |
| Tax provision | $5.63M | -$17.33M | $10.00K | -$45.00K | — | +132.5% |
| Net income | $40.24M | $77.59M | $10.45M | $12.15M | — | -48.1% |
| Net income to common | $40.24M | $77.59M | $10.45M | $12.15M | — | -48.1% |
| Basic EPS | — | 6.42 | 0.87 | 1.02 | -0.58 | — |
| Diluted EPS | — | 5.83 | 0.86 | 1.02 | -0.58 | — |
| EBIT | $49.23M | $64.60M | $21.66M | $21.95M | — | -23.8% |
| EBITDA | $51.05M | $66.34M | $23.24M | $23.05M | — | -23.0% |
| Basic shares | — | 12.09M | 11.99M | 11.86M | 11.68M | — |
| Diluted shares | — | 13.86M | 12.14M | 11.94M | 11.68M | — |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $159.80M | $120.70M | $59.90M | $84.70M | — | +32.4% |
| Cash & short-term investments | $159.80M | $120.70M | $59.90M | $84.70M | — | +32.4% |
| Accounts receivable | $13.49M | $8.88M | $27.89M | $33.15M | — | +52.0% |
| Inventory | $21.56M | $31.61M | $26.41M | $24.24M | — | -31.8% |
| Total current assets | $251.73M | $220.91M | $152.15M | $175.36M | — | +14.0% |
| Property, plant & equipment | $18.20M | $19.00M | $20.60M | $21.60M | — | -4.2% |
| Goodwill & intangibles | $371.00K | $374.00K | $548.00K | $578.00K | — | -0.8% |
| Total assets | $282.00M | $257.76M | $173.29M | $220.85M | — | +9.4% |
| Total current liabilities | $49.22M | $45.56M | $47.59M | $74.85M | — | +8.0% |
| Current debt | — | $0 | $15.45M | $37.47M | $123.50M | — |
| Long-term debt | $75.44M | $95.91M | $95.45M | $131.36M | — | -21.3% |
| Total debt | $89.22M | $111.67M | $128.61M | $187.14M | — | -20.1% |
| Total liabilities | $154.06M | $176.76M | $183.29M | $241.56M | — | -12.8% |
| Retained earnings | -$882.57M | -$923.29M | -$1.00B | -$1.01B | — | +4.4% |
| Shareholder equity | $127.94M | $81.00M | -$10.00M | -$20.71M | — | +58.0% |
| Working capital | $202.51M | $175.35M | $104.55M | $100.51M | — | +15.5% |
| Net tangible assets | $127.57M | $80.63M | -$10.55M | -$21.29M | — | +58.2% |
| Shares issued | 13.32M | 13.17M | 13.10M | 13.09M | — | +1.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $40.24M | $77.59M | $10.45M | $12.15M | — | -48.1% |
| Depreciation & amortisation | $1.81M | $1.73M | $1.58M | $1.10M | — | +4.7% |
| Stock-based compensation | $5.24M | $5.07M | $4.76M | $3.60M | — | +3.4% |
| Change in working capital | $6.61M | $9.37M | -$5.22M | -$11.38M | — | -29.5% |
| Operating cash flow | $62.09M | $74.36M | $14.24M | $7.06M | — | -16.5% |
| Capital expenditure | -$2.86M | -$1.79M | -$1.03M | -$3.30M | — | -59.7% |
| Investing cash flow | -$2.86M | -$1.01M | -$1.03M | $91.65M | — | -183.1% |
| Share buybacks | — | $0 | -$381.00K | — | -$4.25M | — |
| Financing cash flow | -$21.43M | -$13.16M | -$57.30M | -$45.25M | — | -62.8% |
| Free cash flow | $59.23M | $72.57M | $13.21M | $3.75M | — | -18.4% |
| End cash position | $162.34M | $124.56M | $64.32M | $108.57M | — | +30.3% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $159.80M | $128.37M | $120.70M | +24.5% |
| Cash & short-term investments | $159.80M | — | $120.70M | — |
| Accounts receivable | $13.49M | — | $8.88M | — |
| Inventory | $21.56M | — | $31.61M | — |
| Total current assets | $251.73M | $217.47M | $220.91M | +15.8% |
| Property, plant & equipment | $18.20M | $17.50M | $19.00M | +4.0% |
| Goodwill & intangibles | $371.00K | $300.00K | $374.00K | +23.7% |
| Total assets | $282.00M | $248.85M | $257.76M | +13.3% |
| Total current liabilities | $49.22M | — | $45.56M | — |
| Current debt | — | — | $0 | — |
| Long-term debt | $75.44M | $81.98M | $95.91M | -8.0% |
| Total liabilities | $154.06M | — | $176.76M | — |
| Retained earnings | -$882.57M | — | -$923.29M | — |
| Shareholder equity | $127.94M | — | $81.00M | — |
| Working capital | $202.51M | — | $175.35M | — |
| Net tangible assets | $127.57M | $102.86M | $80.63M | +24.0% |
| Shares issued | 13.32M | 13.31M | 13.17M | +0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 3.34 | — | — |
| Dec 2025 | 1.54 | — | — |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | 3.63 | 1 | $0 | — |
| Current year | 3.40 | 1 | $260.64M | +12.1% |
| Next year | 4.29 | 5 | $270.52M | +3.8% |
Analyst targets & ownership
Mean target$88.50
High target$126.10
Low target$59.40
Implied upside37.00%
Analyst count5
ConsensusBUY
Strong buy / Buy1 / 1
Hold1
Sell / Strong sell0 / 0
Held by insiders0.62%
Held by institutions30.89%
Institutions holding80
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
56.93
+13.47% from price
SMA 20
54.27
+19.03% from price
SMA 50
53.09
+21.68% from price
SMA 100
53.21
+21.41% from price
SMA 200
52.82
+22.31% from price
EMA 12
57.84
+11.68% from price
EMA 26
55.21
+17.01% from price
EMA 50
53.93
+19.79% from price
RSI (14)
82.7
Overbought
MACD (12,26,9)
2.63
Hist 1.52
ATR (14)
1.71
2.65% of price
Realised vol 30D
37.2%
Annualised
Bollinger upper
63.46
20, 2σ
Bollinger lower
45.08
20, 2σ
50 / 200 cross
Golden
53.09 vs 52.82
Trend bias
Above 200
+22.31%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.18
Less volatile than market
Correlation to SPY
-0.09
Largely independent
Realised vol 30D
37.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-16.9%
Peak to trough
Max drawdown 5Y
-41.6%
Peak to trough
ATR 14
1.71
2.65% of price
Beta (reported)
0.41
5Y monthly, from filing
Headlines
Nervous About the Stock Market? History Has Encouraging News for Long-Term Investors.
Motley Fool · 9m ago
Johnson & Johnson (JNJ) Wins EU Approval For TECVAYLI Combo In Multiple Myeloma
Simply Wall St. · 16m ago
Will Alaska Air (ALK)ʼs New Seattle–Europe Routes Redefine Its International Growth Narrative?
Simply Wall St. · 16m ago
Traeger (COOK) Stock Fair Value Rises After Q2 Margin Strength Lifts Analyst Targets
Simply Wall St. · 16m ago
Cigna Group (CI) Could Be 19% Undervalued As AI Spotlight Meets Growth Narrative
Simply Wall St. · 17m ago
Is Excelerate Energy (EE) Still Below Fair Value Following Its Recent Rally?
Simply Wall St. · 17m ago
Kane voted German footballer of the year
AFP · 18m ago
Asphalt Expert Robert Stewart Explains Asphalt Driveway Installation Preparation in HelloNation
PR Newswire · 20m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.